INTER MEDICAL FOCSE : revenue, balance sheet and financial ratios

INTER MEDICAL FOCSE is a French company founded 53 years ago, specialized in the sector Location et location-bail d'autres machines, équipements et biens matériels n.c.a. . Based in FREJUS (83600), this company of category PME shows in 2022 a revenue of 1.2 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - INTER MEDICAL FOCSE (SIREN 733750640)
Indicator 2023 2022 2021 2020 2019 2016
Revenue N/C 1 220 756 € N/C N/C N/C 1 014 632 €
Net income 4 975 € 100 794 € 29 039 € 132 926 € 23 235 € 3 366 €
EBITDA N/C 149 726 € N/C N/C N/C 2 391 €
Net margin N/C 8.3% N/C N/C N/C 0.3%

Revenue and income statement

In 2023, INTER MEDICAL FOCSE generates positive net income of 5 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 3 k€ -> 5 k€.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

4 975 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 1%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 56%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

1.32%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

56.297%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

10.2%

Solvency indicators evolution
INTER MEDICAL FOCSE

Sector positioning

Debt ratio
1.32 2023
2021
2022
2023
Q1: -132.67
Med: 0.0
Q3: 28.36
Average -16 pts over 3 years

In 2023, the debt ratio of INTER MEDICAL FOCSE (1.32) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
56.3% 2023
2021
2022
2023
Q1: -59.52%
Med: 29.76%
Q3: 62.25%
Good

In 2023, the financial autonomy of INTER MEDICAL FOCSE (56.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
0.12 years 2022
2022
Q1: 0.0 years
Med: 0.55 years
Q3: 2.29 years
Good

In 2022, the repayment capacity of INTER MEDICAL FOCSE (0.12) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 178.92. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

178.917

Liquidity indicators evolution
INTER MEDICAL FOCSE

Sector positioning

Liquidity ratio
178.92 2023
2021
2022
2023
Q1: 3.93
Med: 103.1
Q3: 273.19
Good -14 pts over 3 years

In 2023, the liquidity ratio of INTER MEDICAL FOCSE (178.92) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
0.28x 2022
2022
Q1: 0.0x
Med: 0.37x
Q3: 3.65x
Average

In 2022, the interest coverage of INTER MEDICAL FOCSE (0.3x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
INTER MEDICAL FOCSE

Positioning of INTER MEDICAL FOCSE in its sector

Comparison with sector Location et location-bail d'autres machines, équipements et biens matériels n.c.a.

Valuation estimate

Indicative estimate only : the number of comparable transactions in this sector is limited (38 transactions). This range of 7 647€ to 28 593€ is provided for information purposes only and requires in-depth analysis to be confirmed.

Estimated enterprise value 2023
Indicative
7k€ 8k€ 28k€
8 767 € Range: 7 647€ - 28 593€
NAF 5 all-time

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 38 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Location et location-bail d'autres machines, équipements et biens matériels n.c.a. )

Compare INTER MEDICAL FOCSE with other companies in the same sector:

Voir toutes les statistiques du secteur Location et location-bail d'autres machines, équipements et biens matériels n.c.a.

Frequently asked questions about INTER MEDICAL FOCSE

What is the revenue of INTER MEDICAL FOCSE ?

The revenue of INTER MEDICAL FOCSE in 2022 is 1.2 M€.

Is INTER MEDICAL FOCSE profitable?

Yes, INTER MEDICAL FOCSE generated a net profit of 5 k€ in 2023.

Where is the headquarters of INTER MEDICAL FOCSE ?

The headquarters of INTER MEDICAL FOCSE is located in FREJUS (83600), in the department Var.

Where to find the tax return of INTER MEDICAL FOCSE ?

The tax return of INTER MEDICAL FOCSE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does INTER MEDICAL FOCSE operate?

INTER MEDICAL FOCSE operates in the sector Location et location-bail d'autres machines, équipements et biens matériels n.c.a. (NAF code 77.39Z). See the 'Sector positioning' section above to compare the company with its competitors.